作者:Stine B. Vogensen、Karla Frydenvang、Jeremy R. Greenwood、Giovanna Postorino、Birgitte Nielsen、Darryl S. Pickering、Bjarke Ebert、Ulrik Bølcho、Jan Egebjerg、Michael Gajhede、Jette S. Kastrup、Tommy N. Johansen、Rasmus P. Clausen、Povl Krogsgaard-Larsen
DOI:10.1021/jm061439q
日期:2007.5.1
Replacement of the methyl group of the AMPA receptor agonist 2-amino-3-[3-hydroxy-5-(2-methyl-2H-5-tetrazolyl)-4-isoxazolyl]propionic acid (2-Me-Tet-AMPA) with a benzyl group provided the first AMPA receptor agonist, compound 7, capable of discriminating GluR2-4 from GluR1 by its more than 10-fold preference for the former receptor subtypes. An X-ray crystallographic analysis of this new analogue in
AMPA受体激动剂2-氨基-3- [3-羟基-5-(2-甲基-2H-5-四唑基)-4-异恶唑基]丙酸(2-Me-Tet-AMPA)的甲基取代带有苄基的化合物提供了第一种AMPA受体激动剂化合物7,该化合物能够以比先前受体亚型高10倍以上的偏好来将GluR2-4与GluR1区分开。对该新类似物与GluR2-S1S2J构建体的复合物的X射线晶体学分析表明,苄基基团的容纳在受体中产生了以前未观察到的口袋,这可能解释了化合物7的显着药理特性。